84 related articles for article (PubMed ID: 3649819)
1. Effect of elevated C1-esterase inhibitor levels on elastase release in vitro--a proposed model of shock (ECC).
Heller W; Fuhrer G; Hoberg S; Hoffmeister HE; Philapitsch A
Prog Clin Biol Res; 1987; 236A():107-14. PubMed ID: 3649819
[No Abstract] [Full Text] [Related]
2. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
[TBL] [Abstract][Full Text] [Related]
3. Elastase release in plasma with increased C1-inhibition capacity during recirculation of blood.
Heller W; Fuhrer G; Philapitsch A; Hoffmeister HE
Adv Exp Med Biol; 1989; 247B():579-84. PubMed ID: 2610094
[No Abstract] [Full Text] [Related]
4. On the role of the C1-esterase inhibitor in cold urticaria.
Nilsson T; Bäck O
Acta Derm Venereol; 1984; 64(3):197-202. PubMed ID: 6204479
[TBL] [Abstract][Full Text] [Related]
5. On the interaction between human plasma kallikrein and C1-esterase inhibitor.
Nilsson T
Thromb Haemost; 1983 Jun; 49(3):193-5. PubMed ID: 6554023
[TBL] [Abstract][Full Text] [Related]
6. Protease inhibitor infusion improves survival rate and hemodynamics in experimental pancreatic shock.
Ruud TE; Aasen AO; Pillgram-Larsen J; Stadaas JO
Prog Clin Biol Res; 1987; 236A():193-201. PubMed ID: 2441408
[No Abstract] [Full Text] [Related]
7. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
[TBL] [Abstract][Full Text] [Related]
8. Plasma kallikrein-kinin system in patients with uncomplicated sepsis and septic shock--comparison with cardiogenic shock.
Martínez-Brotóns F; Oncins JR; Mestres J; Amargós V; Reynaldo C
Thromb Haemost; 1987 Aug; 58(2):709-13. PubMed ID: 3672421
[TBL] [Abstract][Full Text] [Related]
9. Effect of aprotinin and C1-esterase inhibitor on activation of the plasma kallikrein-kinin system in vivo.
Hoffmann H; Siebeck M; Thetter O; Fink E; Philapitsch A
Prog Clin Biol Res; 1987; 236A():159-64. PubMed ID: 2441405
[TBL] [Abstract][Full Text] [Related]
10. Prekallikrein activation in the adult respiratory distress syndrome.
Schapira M; Gardaz JP; Py P; Lew PD; Perrin LH; Suter PM
Bull Eur Physiopathol Respir; 1985; 21(3):237-41. PubMed ID: 3873975
[TBL] [Abstract][Full Text] [Related]
11. Studies on shock during extracorporeal circulation during aorto-coronary bypass operations.
Heller W; Fuhrer G; Hoffmeister HE; Gallimore MJ
Prog Clin Biol Res; 1987; 236A():87-94. PubMed ID: 3497406
[No Abstract] [Full Text] [Related]
12. Kinin activation as a predictive assay for adverse reactions to radiographic contrast medium.
Carr DH; Walker AC
Acta Radiol Diagn (Stockh); 1984; 25(4):337-42. PubMed ID: 6567445
[TBL] [Abstract][Full Text] [Related]
13. A new analytical system for assessing the protease-antiprotease imbalance in intensive-care medicine.
Boulanger J; Ers P; Lemaire MV; Notche M; Adam A
Clin Chem; 1988 Feb; 34(2):464-5. PubMed ID: 3342538
[No Abstract] [Full Text] [Related]
14. Computerized immunoblot analyses (CIBA) of the distribution of prekallikrein and its activation products in vivo and in vitro.
Veloso D; Campbell G
Agents Actions Suppl; 1992; 38 ( Pt 1)():166-73. PubMed ID: 1281607
[TBL] [Abstract][Full Text] [Related]
15. Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulation.
Gikakis N; Khan MM; Hiramatsu Y; Gorman JH; Hack CE; Sun L; Rao AK; Niewiarowski S; Colman RW; Edmunds LH
Circulation; 1996 Nov; 94(9 Suppl):II341-6. PubMed ID: 8901772
[TBL] [Abstract][Full Text] [Related]
16. [Proteinase inhibitors and fibrinogen split products in patients with malignant diseases (author's transl)].
Schwarz HP; Aiginger P; Kuzmits R
Acta Med Austriaca; 1981; 8(1):22-5. PubMed ID: 6165218
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of prekallikrein and kallikrein in pregnancy and labor.
Sayama S; Kashiwagi H; Ogawa T; Terada K; Soma H; Kato M
Int J Biol Res Pregnancy; 1981; 2(2):90-4. PubMed ID: 6916725
[TBL] [Abstract][Full Text] [Related]
18. Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activation.
Wachtfogel YT; Kettner C; Hack CE; Nuijens JH; Reilly TM; Knabb RM; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
Thromb Haemost; 1998 Oct; 80(4):686-91. PubMed ID: 9798991
[TBL] [Abstract][Full Text] [Related]
19. Plasma total prekallikrein/kallikrein activity in rheumatoid arthritis with and without amyloidosis. Increased kaolin-stimulated activity in patients with amyloidosis.
Teppo AM; Pakkanen R; Maury CP
Acta Med Scand; 1985; 217(4):397-402. PubMed ID: 2409750
[TBL] [Abstract][Full Text] [Related]
20. The PFI-index according to Aasen for prognosis and course of polytraumatized patients.
Nast-Kolb D; Waydhas C; Baumgartner I; Jochum M; Duswald KH; Schweiberer L
Prog Clin Biol Res; 1989; 308():731-6. PubMed ID: 2780725
[No Abstract] [Full Text] [Related]
[Next] [New Search]
